Infinium Global Research has added a new report on Global Transcatheter aortic valve replacement (TAVR) Market. The report predicts the market size of Transcatheter aortic valve replacement (TAVR) is expected to reach XX billion by 2022.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve’s place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. Whereas, the TAVR procedures can be done through very small openings that leave all the chest bones in place. There are two methods available for TAVR surgical procedure, which includes:
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/306

Companies profiled:
Edwards Lifesciences Corp.
Boston Scientific Corp.
Direct Flow medical, Inc.
Bracco SpA.
JenaValve Technology, Inc.
Medtronic plc
Meril Life Sciences Pvt. Ltd.
Jude Medical, Inc.
Transcatheter Technologies GmbH.

Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/306

Key topics covered:
1. Scope of the report
2. Executive summary
3. Qualitative analysis
4. Global TAVR market, by type of treatment, 2016 - 2022
5. Global TAVR market, by geography, 2016 - 2022
6. Company profiles

Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/transcatheter_aortic_valve_replacement_tavr_market